IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — EMR

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents1.791.752.221.892.832.302.322.089.962.052.272.536.934.732.862.342.20
Accounts Receivable3.162.972.912.902.692.762.882.762.492.332.232.962.962.752.752.752.65
Inventory2.452.352.292.222.202.302.362.432.092.032.002.322.402.342.112.022.01
Total Current Assets9.258.849.078.639.198.829.018.6715.768.999.009.3813.5410.868.777.967.68
Property, Plant & Equipment2.852.872.792.762.742.692.692.702.272.262.263.363.573.693.663.663.69
Goodwill18.1518.1818.1618.0017.9117.9417.9617.9814.1314.1014.0914.757.637.707.787.797.83
Intangible Assets8.959.219.679.8210.0310.6310.9811.276.156.306.466.932.702.792.993.103.20
Total Non-current Assets*32.8433.1033.4533.3533.4236.7737.4337.8528.4127.1627.2427.6715.9616.1015.7215.8416.00
Total Assets42.0941.9442.5241.9842.6145.5946.4446.5144.1736.1536.2437.0429.5026.9624.4823.8023.68
Accounts Payable1.471.341.271.341.261.251.271.231.221.211.222.042.052.101.971.801.69
Short-term Debt5.805.835.956.191.072.993.163.230.671.961.793.232.760.041.481.461.72
Total Current Liabilities10.6510.5210.7310.855.967.597.667.776.617.558.168.818.075.336.676.296.38
Long-term Debt7.567.588.288.186.567.117.617.637.648.178.168.378.208.725.845.825.89
Total Non-current Liabilities*11.1311.1411.9211.8816.1617.1917.8818.0717.1017.2417.3517.9210.8511.388.528.388.41
Total Liabilities*21.7921.6622.6522.7322.1224.7925.5425.8423.7124.7925.5126.7318.9216.7115.1914.6714.78
Retained Earnings41.1840.8740.2739.9841.1140.1440.1139.9139.6230.5730.0827.6227.0026.6425.6825.3525.10
Total Stockholder Equity20.3020.2819.8719.2520.4920.8020.9020.6720.4611.3610.7310.3210.5810.259.299.138.90

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue4.564.354.864.554.434.184.624.384.384.124.093.953.763.375.365.014.794.474.954.70
Cost of Revenue2.142.042.342.162.061.942.252.072.092.202.081.951.961.753.042.912.842.652.952.72
Gross Profit2.422.312.522.392.372.242.372.312.281.922.011.991.801.622.322.101.951.822.001.98
Selling, General & Admin1.321.241.331.271.281.221.321.251.301.281.111.041.001.031.141.051.051.011.051.07
Pretax Income0.790.780.800.730.630.780.770.460.650.140.900.760.640.420.901.200.811.180.830.78
Tax Provision0.180.170.160.150.200.180.170.090.150.010.210.160.130.100.200.240.140.280.150.15
Net Income0.620.610.640.590.490.591.000.330.500.140.749.350.792.330.740.920.670.900.670.63
Basic EPS--1.081.131.040.861.031.740.580.870.251.2616.361.393.991.251.551.131.511.121.05
Diluted EPS--1.071.121.040.861.021.740.570.870.251.2516.281.383.971.241.541.131.501.111.04

Cash Flow Statement

(in billions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow0.780.701.011.070.240.781.081.090.740.42(0.64)0.790.070.421.220.740.440.520.861.11
Capital Expenditures0.090.100.170.090.090.080.170.090.080.080.170.070.060.060.200.110.110.120.230.13
Free Cash Flow*0.690.600.840.980.150.690.921.000.660.34(0.81)0.720.010.361.020.630.330.410.620.98
Investing Cash Flow(0.08)(0.12)(0.20)(0.13)(0.12)(0.14)3.20(0.07)(0.04)(8.45)(0.68)10.37(0.15)2.89(0.36)(5.13)(0.13)0.28(0.21)(0.14)
Financing Cash Flow(0.65)(0.36)(1.49)(0.64)(1.09)(1.29)(3.04)(1.03)(0.44)2.06(0.52)(3.27)(0.14)(2.89)(1.51)0.061.901.60(1.13)(0.45)

* Derived from reported values

Dividends Per Share

(USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Dividends Per Share0.560.560.530.530.530.530.530.530.530.530.520.520.520.520.520.520.520.520.510.51